Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Supernus Pharmaceuticals Inc. (SUPN)

24   0.06 (0.25%) 02-14 16:00
Open: 23.87 Pre. Close: 23.94
High: 24.04 Low: 23.65
Volume: 444,174 Market Cap: 1259M
Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 24.076 - 24.173 24.173 - 24.273
Low: 23.411 - 23.512 23.512 - 23.616
Close: 23.834 - 24.01 24.01 - 24.191

Technical analysis

as of: 2020-02-14 4:32:52 PM
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 29.39     One year: 34.32
Support: Support1: 23.65    Support2: 22.71
Resistance: Resistance1: 25.16    Resistance2: 29.39
Pivot: 23.63
Moving Average: MA(5): 23.77     MA(20): 23.78
MA(100): 24.32     MA(250): 29.60
MACD: MACD(12,26): 0.03     Signal(9): 0.02
Stochastic oscillator: %K(14,3): 68.86     %D(3): 55.73
RSI: RSI(14): 53.96
52-week: High: 43.05  Low: 19.35  Change(%): -37.0
Average Vol(K): 3-Month: 54619  10-Days: 37439

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
SUPN has closed below upper band by 22.4%. Bollinger Bands are 63.1% narrower than normal. The narrow width of the bands suggests low volatility as compared to SUPN's normal range. The bands have been in this narrow range for 54 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Can Value Investors Pick Supernus Pharmaceuticals (SUPN) Stock?
Is Supernus Pharmaceuticals (SUPN) a great pick from the value investor's perspective right now? Read on to know more.

The Daily Biotech Pulse: Obseva Sinks On Adverse Clinical Readout, BioNano Surges On Saphyr Adoption, 2 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Nov. 6) Agile Therapeutics Inc (NASDAQ: AGRX )(follow-on rally following positive Adcom verdict for Twirla) Constellation Pharmaceuticals Inc (NASDAQ: CNST )(announced positive results from a Phase 2 trial of CPI-0610 in combination with Jakafi in myelofibrosis) Exagen Inc (NASDAQ: XGN ) INNATE PHARMA S/S ADR (NASDAQ: IPHA ) Momenta Pharmaceuticals, Inc. (NASDAQ: MNTA ) Repro-Med Systems, Inc. (NASDAQ: KRMD ) TFF Pharmaceuticals Inc (NASDAQ: TFFP ) Viela Bio Inc (NASDAQ: VIE ) (IPOed Oct. 3) ZEALAND PHARMA/S ADR (NASDAQ: ZEAL ) Down In The Dumps (Biotech stocks hitting 52-week lows on Nov. 6) AcelRx Pharmaceuticals Inc (NASDAQ: ACRX ) Achieve Life Sciences Inc (NASDAQ: ACHV ) AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO ) Biocept Inc (NASDAQ: BIOC ) bluebird bio Inc (NASDAQ: BLUE ) Cocrystal Pharma Inc (NASDAQ: COCP ) Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP ) Cyclerion Therapeutics Inc (NASDAQ: CYCN ) Diffusion Pharmaceuticals Inc (NASDAQ: DFFN ) Exelixis, Inc.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 52.46
Shares Float (M) 50.71
% Held by Insiders 3.38
% Held by Institutions 98.16
Shares Short (K) 5920
Shares Short P. Month (K)

Stock Financials

EPS 1.960
Book Value (p.s.) 10.620
PEG Ratio 0.31
Profit Margin 25.92
Operating Margin 36.16
Return on Assets (ttm) 9.1
Return on Equity (ttm) 21.6
Qtrly Rev. Growth -0.8
Gross Profit (p.s.) 7.502
Sales Per Share
EBITDA (p.s.) 2.942
Qtrly Earnings Growth 3.00
Operating Cash Flow (M) 132.19
Levered Free Cash Flow (M) 102.04

Stock Valuations

P/E 12.24
P/E Growth Ratio
P/BV 2.26
P/S 3.07
P/CF 9.52

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.